IGC Pharma targets Alzheimer’s market with anti-amyloid drug candidate

Green Market Report
By Adam JacksonSep 4, 2024, 11:41 am185 ptsTop
IGC Pharma Inc. (NYSE: IGC), which was formerly known as India Globalization Capital, announced Wednesday it plans to advance its drug candidate IGC-AD1 into clinical trials as a potential anti-amyloid treatment for Alzheimer’s disease. The move follows recent FDA approvals of anti-amyloid drugs from Eli…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Marijuana operator Gold Flora facing receivership amid financial challenges 68

LeafLink buys online wholesale competitor Leaf Trade 67

Kentucky issues medical marijuana permits amid out-of-state controversy 66

Teens in Danger: How Marijuana Legalization is Fueling a Youth Addiction Crisis 65

Cannabis company Canopy Growth appoints Luc Mongeau as CEO 63

Cannabis wholesale platform LeafLink buys Leaf Trade 62

POSaBIT reports third-quarter loss despite payment platform growth 59

What to expect from next week’s cannabis rescheduling hearing 58

About NewsBudz

NewsBudz is a marijuana and medical cannabis news app. The site delivers a daily feed of the latest cannabis news. We aggregate over 30 of the web's best sources for news about marijuana, hemp and legalization to keep you informed.

Stay on top of the latest news headlines, trends and developments worldwide around recreational and medical marijuana. Sit back and relax, while you read learn and share. On the web or your mobile device, NewsBudz is your cannabis news stream.